A PHASE 3 STUDY OF FIXED DOSE COMBINATIONS OF FIANLIMABAND CEMIPLIMAB VERSUS RELATLIMAB AND NIVOLUMAB IN PARTICIPANTS WITH UNRESECTABLE OR METASTATIC MELANOMA
Clinical Trial Grant
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
June 5, 2025
End Date
June 12, 2030
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
June 5, 2025
End Date
June 12, 2030